M&A - electroCore, Inc.

Form Type: 10-K

Filing Date: 2025-03-12

Corporate Action: Acquisition

Type: Update

Accession Number: 000121390025023259

Filing Summary: This Annual Report on Form 10-K for electroCore, Inc. covers the fiscal year ending December 31, 2024. The document discusses the company's business operations, market environment, and the risks associated with its products. It highlights the company's recent acquisition of NeuroMetrix, Inc., which is subject to customary closing conditions. Key financial details include an aggregate market value of approximately $34.86 million of common equity. The company has introduced a new wellness product, Truvaga, and is evaluating its market acceptance. There are ongoing concerns regarding revenue dependency on a limited number of customers and substantial uncertainty regarding regulatory environments. It also addresses the history of financial losses, the potential need for additional funds, and other operational risks related to supply chains and competitive pressures in its market.

Document Link: View Document

Form Type: S-3

Filing Date: 2025-01-24

Corporate Action: Acquisition

Type: New

Accession Number: 000119380525000090

Filing Summary: On January 24, 2025, electroCore, Inc. filed a registration statement on Form S-3 with the SEC. This statement is a replacement registration statement being filed under Rule 415(a)(6) in relation to approximately $46.2 million of unsold securities from a previous filing on Form S-3 (Registration No. 333-262223), effective since January 25, 2022. The current registration allows electroCore to offer and sell up to $100 million of a combination of its common stock, preferred stock, warrants, debt securities, rights, and units. The offering may take place from time to time depending on market conditions. Additionally, electroCore has announced a definitive agreement to acquire NeuroMetrix, Inc., which involves the understanding that the acquisition will be subject to certain conditions, including shareholder approval and compliance with SEC filing requirements. The prospectus states that the nets proceeds from offered securities will be used for sales and marketing, working capital, and possibly for future acquisitions.

Document Link: View Document